New classification for sleep apnea based on daytime sleepiness and heart risk
Official title: A Modified Baveno Classification of Obstructive Sleep Apnoea Based on Sleepiness and Cardiovascular Scores: A Prospective Observational Cohort Study
Run by Wissenschaftliches Institut Bethanien e.V · NCT06861686 · Data updated 2026-11-12
We will test whether combining daytime sleepiness and cardiovascular risk scores can better predict long-term outcomes for adults newly diagnosed with obstructive sleep apnea.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 40 Years and up |
| Sex | All |
| Enrollment | 1800 (estimated) |
| Sponsor | Wissenschaftliches Institut Bethanien e.V Academic / other |
| Locations | 18 sites (Antwerp, Antwerp and 17 other locations) |
| Status | Recruiting |
| Started | March 24, 2025 |
| Main results expected | March 31, 2030 |
| Study ends | March 31, 2030 |
| Registry record updated | December 12, 2025 |
| Trial ID | NCT06861686 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 40 years or older with newly diagnosed predominantly obstructive sleep apnea (AHI ≥5) who have not received sleep apnea treatment in the past 12 months and have fewer than 30% central events are ideal candidates.
✕Probably not a fit
Patients with primarily central sleep apnea (>30% central events), those already treated for sleep apnea within the last year, or adults under 40 are unlikely to benefit from this classification.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study will enroll adults aged 40 and older with newly diagnosed predominantly obstructive sleep apnea (AHI ≥5) at centers in Belgium and France. Investigators will apply a modified Baveno classification that combines measures of daytime sleepiness and cardiovascular risk, using diagnostic polysomnography or polygraphy per local standards. Participants will be followed over time for objective measures (repeat sleep testing) and subjective outcomes (sleepiness questionnaires and clinical cardiovascular events) without introducing experimental treatments. The aim is to determine whether the new classification correlates with long-term improvement and cardiovascular risk.
Why it matters
Potential benefit: If successful, the classification could help clinicians identify patients at higher cardiovascular risk and tailor monitoring or treatment intensity accordingly.
How similar studies have gone: Similar approaches combining sleepiness and cardiovascular risk have been proposed, but they remain relatively untested in large prospective cohorts.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria 1. Adult patient ≥40 years at the time of signed informed consent 2. Diagnosis of predominant obstructive sleep apnoea with a total apnoea-hypopnoea index of ≥5 /h based on a diagnostic sleep study (polysomnography or polygraphy, as per local standard). Predominant obstructive sleep apnoea defined as ≥70% of respiratory events classified as obstructive. 3. Signed and dated written informed consent in accordance with ICH-GCP and applicable local regulations Exclusion criteria 1. \>30% central respiratory events (apnoeas and hypopnoeas) within the diagnostic sleep study 2. Established sleep apnoea treatment within the last 12 months before study inclusion (positive airway pressure, mandibular advancement device, positional therapy) 3. Use, or need for chronic use, of any non-invasive positive pressure ventilation device 4. Participation in an interventional study and/or receiving investigational treatment(s) 5. Significant disease or condition, which, in the opinion of the investigator, may interfere with study procedures or cause concern regarding the patient's ability to participate in the study 6. Patients not expected to comply with the protocol requirements or not expected to complete the trial as scheduled (e.g. chronic alcohol or drug abuse or any other condition that, in the investigator's opinion, makes the patient an unreliable trial participant)
Where it's running
-
UZ Leuven
Leuven, Vlaams-Brabant, Belgium Recruiting -
Wissenschaftliches Institut Bethanien für Pneumologie e.V.
Solingen, Germany Recruiting -
Department of Pulmonology, University General Hospital of Alexandroupolis, Medical School, Democritus University of Thrace
Alexandroupoli, Evros, Greece Recruiting -
University of Crete
Heraklion, Greece Recruiting -
Istituti Clinici Scientifici Maugeri IRCCS
Pavia, Italy Recruiting -
Institute of Tuberculosis and Lung Diseases
Warsaw, Masovian Voivodeship, Poland Recruiting
Show 12 more locations
-
Unidade Local de Saúde de Gaia e Espinho ULSGE - Unidade de Patologia do Sons
Vila Nova de Gaia, Porto District, Portugal Recruiting -
Hospital Beatriz Ângelo, Unidade Local de Saúde Loures-Odivelas
Loures, Portugal Recruiting -
Clinica Somnolog
Bucharest, Romania Recruiting -
University of Medicine and Pharmacy Dr. Victor Babes
Timișoara, Romania Recruiting -
University Clinic of Respiratory and Allergic Diseases Golnik
Golnik, Slovenia Recruiting -
Ege University, Faculty of Medicine, Department of Respiratory Medicine
Izmir, Turkey (Türkiye) Recruiting -
Antwerp University Hospital
Antwerp, Antwerp, Belgium Not yet recruiting -
Centre Hospitalier Universitaire Grenoble Alpes
Grenoble, Isère, France Not yet recruiting -
Division of Pulmonology, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Medical School
Athens, Greece Not yet recruiting -
Respiratory Failure Unit, G. Papanikolaou Hospital
Thessaloniki, Greece Not yet recruiting -
Istituto Auxologico Italiano
Milan, Italy Not yet recruiting -
Klinik für Pneumologie Universitätsspital Zürich
Zurich, Switzerland Not yet recruiting
Study contacts
- Principal investigator: Winfried J Randerath, Prof. Dr. — Wissenschaftliches Institut Bethanien für Pneumologie e.V.
- Study coordinator: Marcel Treml, Dr.
- Email: marcel.treml@klinik-bethanien.de
- Phone: +49212636661
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
F&P Mask usability in home PAP/NIV care for adults with chronic breathing conditions
This study tests how well the F&P Licorice Mask works at home for adults who already use PAP or NIV therapy.
-
Sleep apnea biomarkers and CPAP use after diagnosis
This study tests whether biomarkers from a diagnostic sleep study can predict how well adults with newly diagnosed obstructive sleep apnea will stick to CPAP therapy after about 3 months.
-
Using the PLATO Questionnaire in Oral Appliance Therapy for Obstructive Sleep Apnea
This real-world study tests whether the PLATO questionnaire can be feasibly used in dental sleep clinics for patients receiving oral appliance therapy for obstructive sleep apnea.
-
Managing COMISA: adding daridorexant to CPAP may help sleep and CPAP use
This study tests whether adding daridorexant to CPAP helps people with COMISA better stick with CPAP and feel better.
-
OSA Screening in Diverse Populations
This study tests how common obstructive sleep apnea is across community members and people with certain diseases in China, using screening questionnaires and polysomnography or portable sleep monitors.
-
Wall Squat Exercise to Help Lower Blood Pressure in Adults with Hypertension and Sleep Apnea
This study tests whether doing an isometric wall squat can lower blood pressure in adults who have high blood pressure and sleep apnea treated with CPAP.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.